Inex Pharmaceuticals赞助的临床试验
总计19767个结果
-
Regeneron PharmaceuticalsAlnylam Pharmaceuticals完全的
-
ISA PharmaceuticalsRegeneron Pharmaceuticals主动,不招人口咽鳞状细胞癌美国, 以色列, 比利时, 德国, 西班牙, 英国, 意大利, 法国, 捷克语
-
Jazz PharmaceuticalsGW Pharmaceuticals终止
-
Alexion PharmaceuticalsPortola Pharmaceuticals完全的滤泡性淋巴瘤(FL/惰性 NHL) | 侵略性 NHL(一种 NHL) | 慢性淋巴细胞白血病 (CLL) / 小淋巴细胞淋巴瘤 (SLL) | T 细胞淋巴瘤(PTCL 和 CTCL) | B 细胞非霍奇金淋巴瘤 (NHL)美国
-
Assistance Publique - Hôpitaux de ParisEvolucare Technologies; InES - Innovation Electronic Software尚未招聘
-
Centre Hospitalier Régional d'OrléansImmunologie et Neurogénétique Expérimentales et Moléculaires (INEM)撤销
-
Bone Index Finland LtdNew Mexico Clincial Research & Osteoporosis Center, Inc.完全的
-
Guelph Food Research CentreUniversity of Manitoba; Glycemic Index Laboratories, Inc完全的
-
Mondelēz International, Inc.University of Sydney; Glycemic Index Laboratories, Inc; BioFortis完全的
-
Glycemic Index Laboratories, IncCanadian Center for Functional Medicine; InovoBiologic Inc.完全的
-
NovaBay Pharmaceuticals, Inc.Novum Pharmaceutical Research Services; International Dermatology Research, Inc.完全的
-
PETHEMA FoundationMillennium Pharmaceuticals, Inc.; Johnson & Johnson Pharmaceutical Research & Development, L...完全的
-
Assistance Publique - Hôpitaux de ParisEvolucare Technologies; InES - Innovation Electronic Software未知
-
Glycemic Index Laboratories, IncCanadian Center for Functional Medicine; InovoBiologic Inc.完全的
-
Douglas Pharmaceuticals America LtdNovum Pharmaceutical Research Services; ACM Global Laboratories完全的
-
Regeneron PharmaceuticalsISA Pharmaceuticals B.V.主动,不招人宫颈癌西班牙, 大韩民国, 荷兰, 巴西, 比利时, 美国, 意大利, 俄罗斯联邦
-
Ligand PharmaceuticalsCyDex Pharmaceuticals, Inc.撤销
-
Paratek Pharmaceuticals IncNovartis Pharmaceuticals终止
-
Vertex Pharmaceuticals IncorporatedJanssen Pharmaceuticals终止
-
Semafore PharmaceuticalsSignalRX Pharmaceuticals, Inc.完全的
-
Conatus Pharmaceuticals Inc.Idun Pharmaceuticals完全的
-
Johnson & Johnson Pharmaceutical Research & Development...Janssen Pharmaceutica N.V., Belgium完全的
-
Johnson & Johnson Pharmaceutical Research & Development...Janssen Pharmaceutica N.V., Belgium完全的药代动力学 | 晚期恶性肿瘤 | 实体恶性肿瘤 | 蛋白激酶抑制剂 | 最大耐受剂量 | 抗肿瘤方案 | 临床试验,第一阶段
-
Guelph Food Research CentreGlycemic Index Laboratories, Inc; Ontario Bean Growers Association完全的
-
Glycemic Index Laboratories, IncPepsiCo Global R&D; Applied Statistics and Consulting完全的
-
Institut BergoniéBristol-Myers Squibb; Amgen; Aventis Pharmaceuticals; Sanofi-Synthelabo; Chugai Pharmaceutical完全的消化系统疾病 | 淋巴瘤 | 卵巢疾病 | 肺病 | 膀胱疾病 | 前列腺疾病法国
-
Foresee Pharmaceuticals Co., Ltd.QPS Holdings LLC; Changchun GeneScience Pharmaceutical Co., Ltd.招聘中
-
Henan Cancer HospitalQilu Pharmaceutical Co., Ltd.; Beijing Biostar Pharmaceuticals Co., Ltd.尚未招聘HER-2 阴性乳腺癌
-
Ferring PharmaceuticalsFerring Pharmaceuticals Korea, Ltd.完全的
-
Regeneron Pharmaceuticals尚未招聘黑色素瘤 | 晚期实体瘤 | 透明细胞肾细胞癌 (ccRCC)
-
Regeneron Pharmaceuticals尚未招聘视力障碍 | 糖尿病性黄斑水肿 (DME) | 新生血管性年龄相关性黄斑变性 (nAMD) | 湿性年龄相关性黄斑变性 (AMD)
-
Ferring Pharmaceuticals尚未招聘
-
Regeneron Pharmaceuticals尚未招聘肌萎缩侧索硬化症 (ALS) | 超氧化物歧化酶 1 (SOD1) 基因突变
-
Regeneron Pharmaceuticals尚未招聘
-
Regeneron Pharmaceuticals尚未招聘
-
Regeneron Pharmaceuticals招聘中